DMIIU Drugs Made In America Acquisition II Corp. - Unit
$10.20
Price · Aug 18, 2026
Fundamentals as of Aug 14, 2026
52W Range
$10–$11
31% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-46.6%
Net Profit Margin
—
DMIIU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.20
Market Cap
$140M
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-46.6%
Debt/Equity
—
52W Range
$10 – $11
DMIIU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DMIIU
Peer Median
P/B
-7.9
1.0
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DMIIU
Peer Median
ROA
1.7%
2.0%
ROE
-46.6%
2.0%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DMIIU
Peer Median
Current Ratio
0.1
0.5
Quick Ratio
0.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DMIIU
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DMIIU
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 7
| Metric | Trend | 2025 |
|---|---|---|
| SG&A Expense | $488.4K | |
| Operating Expenses | $488.4K | |
| Operating Income | $-488.4K | |
| Interest Income | $5M | |
| Other Non-op | $5M | |
| Net Income | $4M | |
| EBITDA | $-488.4K |
Balance Sheet 13
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $223 | |
| Prepaid Expense | $25.8K | |
| Current Assets | $26.0K | |
| Total Assets | $505M | |
| Accounts Payable | $99.4K | |
| Accrued Liabilities | $88.3K | |
| Current Liabilities | $300.9K | |
| Total Liabilities | $18M | |
| Common Stock | $1.4K | |
| Retained Earnings | $-18M | |
| Stockholders' Equity | $-18M | |
| Liabilities + Equity | $505M | |
| Shares Outstanding | 13,700,000 |
Cash Flow 3
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-1M | |
| Investing Cash Flow | $-500M | |
| Financing Cash Flow | $501M |
Profitability 2
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 1.7% | |
| ROE | -46.6% |
Liquidity & Solvency 2
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 0.1 | |
| Quick Ratio | 0.0 |
Valuation (TTM) 4
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $4M | |
| Market Cap | $137M | |
| P/B | -7.7 | |
| P / Cash Flow | -134.7 |
Income Statement 7
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| SG&A Expense | $112.2K | $235.5K | $155.5K | |
| Operating Expenses | $112.2K | · | · | |
| Operating Income | $-112.2K | $-235.5K | $-155.5K | |
| Interest Income | $5M | $5M | $109.4K | |
| Other Non-op | $5M | $5M | $109.4K | |
| Net Income | $4M | $4M | $-46.2K | |
| EBITDA | $-112.2K | · | $-155.5K |
Balance Sheet 15
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $175.0K | $223 | $315.1K | |
| Prepaid Expense | $42.8K | $25.8K | $15.0K | |
| Current Assets | $217.8K | $26.0K | $896.4K | |
| Total Assets | $514M | $505M | $501M | |
| Accounts Payable | $12.3K | $99.4K | $4.6K | |
| Accrued Liabilities | $69.2K | $88.3K | $5.8K | |
| Short-term Debt | $450.0K | · | · | |
| Current Liabilities | $644.6K | $300.9K | $677.3K | |
| Total Liabilities | $18M | $18M | $18M | |
| Total Debt | $450.0K | · | · | |
| Common Stock | $1.4K | $1.4K | $1.6K | |
| Retained Earnings | $-18M | $-18M | $-17M | |
| Stockholders' Equity | $-18M | $-18M | $-17M | |
| Liabilities + Equity | $514M | $505M | $501M | |
| Shares Outstanding | 13,700,000 | 13,700,000 | 15,575,000 |
Cash Flow 3
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Operating Cash Flow | $-172.7K | $-314.9K | $-690.7K | |
| Investing Cash Flow | · | $0 | · | |
| Financing Cash Flow | $0 | $0 | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| ROA | 1.7% | · | -0.02% | |
| ROE | -49.0% | · | 0.53% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Current Ratio | 0.3 | · | 1.3 | |
| Quick Ratio | 0.3 | · | 0.5 | |
| Debt / Equity | -0.0 | · | · |
Valuation (TTM) 5
| Metric | Trend | Q2 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Net Income TTM | $9M | · | · | |
| Market Cap | $139M | · | $155M | |
| Enterprise Value | $139M | · | · | |
| P/B | -7.8 | · | -9.0 | |
| EV / EBITDA | -1242.7 | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $4M | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 0.1 | — |
| Quick Ratio | 0.0 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 12 filers · $34.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (-1 vs prior Q) | 3 (-14 vs prior Q) | 1 (0 vs prior Q) | 3 (-1 vs prior Q) | -907K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| LMR Partners LLP | $20,320,000 | 2,000,000 | 58.87% | Shares |
| Westchester Capital Management, LLC | $4,643,059 | 456,994 | 13.45% | Shares |
| Verition Fund Management LLC | $2,540,000 | 250,000 | 7.36% | Shares |
| BlueCrest Capital Management Ltd | $2,540,000 | 250,000 | 7.36% | Shares |
| Walleye Capital LLC | $1,016,000 | 100,000 | 2.94% | Shares |
| L1 Global Manager Pty Ltd | $1,016,000 | 100,000 | 2.94% | Shares |
| READYSTATE ASSET MANAGEMENT LP | $1,016,000 | 100,000 | 2.94% | Shares |
| Maso Capital Partners Ltd | $994,500 | 100,000 | 2.88% | Shares |
| Rangeley Capital, LLC | $330,718 | 32,551 | 0.96% | Shares |
| Clear Street Group Inc. | $82,133 | 8,084 | 0.24% | Shares |
| UBS Group AG | $17,932 | 1,765 | 0.05% | Shares |
| HRT FINANCIAL LP | $1,013 | 99,725 | 0.00% | Shares |